Caplyta’s most recent FDA approval is based on positive results from two Phase III clinical trials: Study 501 (NCT04985942) and Study 502 (NCT05061706). Both studies met their primary endpoint and key ...
Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...
The FDA has approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for treating major depressive ...
CAPLYTA®, in combination with an oral antidepressant, demonstrated superior efficacy with a favorable safety and tolerability profile consistent with ...
QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in CashRepresents a 139.7% premium to most recent ...
The Food and Drug Administration (FDA) has approved Caplyta ® (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class ...
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora's M4 franchise; both programs have potential best-in-class pharmacology No convulsions observed in pre-clinical stud ...
Liver cancer is often called a ‘silent killer’ because it often develops quietly, showing little to no obvious symptoms in early stages. It is assumed that loss of appetite is an early warning sign of ...
We’ve all experienced common issues like headaches, vision changes, nausea, stomach pain, and mouth sores. These don’t tend to cause us much worry because they’re usually symptoms of benign issues ...
Cases of womb cancer have risen by 50 per cent over the past 20 years, but many women do not know the warning signs. The disease, which is also sometimes called endometrial or uterine cancer, is found ...
Vitamin K, crucial for blood clotting and bone health, is often overlooked. Deficiency symptoms include easy bruising, heavy menstrual bleeding, and bleeding gums. Low K2 can lead to bone weakness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback